Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis

Published:2017-12-04 Issue:2 Volume:47 Page:162-175
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Singh S.¹²^ORCID,Fumery M.¹³,Sandborn W. J.¹,Murad M. H.⁴

Affiliation:

1. Division of Gastroenterology; University of California San Diego; La Jolla CA USA

2. Division of Biomedical Informatics; University of California San Diego; La Jolla CA USA

3. Gastroenterology Unit; Amiens University and Hospital; Université de Picardie Jules Verne; Amiens France

4. Robert D and Patricia E Kern Center for the Science of Health Care Delivery; Mayo Clinic; Rochester MN USA

Funder

Crohn's and Colitis Foundation of America

American College of Gastroenterology

U.S. National Library of Medicine

Société Nationale Française de Gastro-Entérologie

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14422/fullpdf

Reference37 articles.

1. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

2. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review;Fumery;Clin Gastroenterol Hepatol,2017

3. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy;Vester-Andersen;Am J Gastroenterol,2014

4. Assessing response and loss of response to biological therapies in IBD;Yanai;Am J Gastroenterol,2011

5. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis;Ford;Am J Gastroenterol,2011

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Positive Psychological Interventions on Psychological Outcomes, Quality of Life, and Inflammation Biomarkers in Inflammatory Bowel Disease Patients: A Meta-Analysis of Randomized Controlled Trials;Gastroenterology Nursing;2024-09-05

2. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25

3. Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study;American Journal of Gastroenterology;2024-07-05

4. Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis;Digestive and Liver Disease;2024-07

5. Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis;Cureus;2024-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3